MAM
NH

Meeder Asset Management’s NantHealth, Inc NH Stock Holding History

Meeder Asset Management’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-32
Closed -$2K – 1949
2017
Q1 		$2K Buy
32
+13
+68% +$1.45K ﹤0.01% 1432
2016
Q4 		$3K Buy
+19
New +$3.36K ﹤0.01% 915

Other funds holding NH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Meeder Asset Management's NH Position: Q2 2017 in Review

Meeder Asset Management sold out of NantHealth, Inc (NH) in Q2 2017, closing a stake of 32 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in NH in Q4 2016 and held it in 2 quarters. The position peaked at $3K in Q4 2016. 46 funds tracked by Wall St. Rank hold NH as of Q2 2017.

  • Meeder Asset Management reported no remaining NantHealth, Inc position as of Q2 2017 after selling out during the quarter.
  • Meeder Asset Management sold 32 NantHealth, Inc shares in Q2 2017, an estimated $2K.
  • Meeder Asset Management first reported a position in NantHealth, Inc in Q4 2016 and held it in 2 quarters.
  • Meeder Asset Management's NantHealth, Inc position peaked at $3K in Q4 2016.
  • 46 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2017.

Based on Meeder Asset Management's 13F filing for Q2 2017, filed 13 Jul 2017.